2.2. Participants
Untreated cancer, pneumonia, urinary-tract infection, neuropathy, trauma, cancer, proteinuria, liver disease, paralysis, fractures, Dementia, renal dysfunction, diabetes
PNEUMONIA, NEUROPATHY, CANCER, INFECTIOUS DISEASE, LIVER DISEASE, CENTRAL NERVOUS SYSTEM DISEASE, HEART, PROLIFERATIVE RETINOPATHY, COMPLICATIONS, DIABETES
All participants were adults aged 75 or older who were admitted to one of 7 participating hospitals in Japan for treatable cancer, pneumonia, fractures, and/or urinary-tract infection and were at nutritional risk, scoring below 11 on the Mini Nutritional Assessment Short Form, a simple evaluation questionnaire for nutritional state [Dementia (Mini-Cog score below 3 [Current steroid use.Moderate or severe liver disease (Child-Pugh classification above 7) or moderate to severe renal dysfunction (serum creatinine above 2.0 mg/dL).Heart failure that restricted physical activity (New York Heart Association functional classification of II or greater).Severe, chronic complications of diabetes such as overt proteinuria, proliferative retinopathy or severe neuropathy.Infectious disease of the systemic inflammatory reaction group or trauma (4 or higher on the abbreviated injury scale).Gastrointestinal reconstruction surgery.Untreated cancer.Cardiac pacemaker or implanted defibrillator.Limb motor paralysis due to central nervous system disease.Participation in this clinical study deemed not appropriate.